Neurotherapeutic potential of synthetic cannabinoid receptor agonist, WIN55,212-2 on Aluminium chloride and D-galactose- induced cognitive impairments in male Wistar rats
Cognitive impairments and neurotransmission dysfunction have been linked to old age diseases including Alzheimer’s disease (AD). Aluminium has been reported to act as a neurotoxic metal, whereas D-galactose (D-gal) has been established to be a senescence agent. Donepezil is in a class of medications...
Main Author: | Onesimus, Mahdi |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/98207/1/FPSK%28p%29%202021%2022%20IR.pdf |
Similar Items
-
Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
by: Oyku Zeynep Gercek, et al.
Published: (2020-07-01) -
Microinjection of WIN55,212-2 as a Cannabinoid Agonist into the Basolateral Amygdala Induces Sensitization to Morphine in Rats
by: Marzieh Molaei, et al.
Published: (2014-11-01) -
Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation
by: Mario Pérez-Diego, et al.
Published: (2023-03-01) -
A male mouse model of WIN 55,212–2 self-administration to study cannabinoid addiction
by: María del Mar Cajiao-Manrique, et al.
Published: (2023-03-01) -
EFFECTS OF SYNTETIC CANNABINOID RECEPTOR LIGANDS WIN 55.212-2 AND ANANDAMID UPON IN VITRO ACTIVITY OF IMMUNOCOMPETENT CELLS
by: E. G. Lobanova
Published: (2014-07-01)